The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II clinical trial of first-line combination of radiation followed by gemcitabine, dexamethasone, and cisplatin (GDP) chemotherapy for early-stage extranodal natural killer/T-cell lymphoma with unfavorable prognostic factors: The GREEN study (NCT02276248).
 
Fei Qi
No Relationships to Disclose
 
Wei-Hu Wang
No Relationships to Disclose
 
Ye-Xiong Li
No Relationships to Disclose
 
Mei Dong
No Relationships to Disclose
 
Xiao-hui He
No Relationships to Disclose
 
Jianliang Yang
No Relationships to Disclose
 
Sheng Yang
No Relationships to Disclose
 
Hui Fang
No Relationships to Disclose
 
Bo Chen
No Relationships to Disclose
 
Shunan Qi
No Relationships to Disclose
 
Yan Qin
No Relationships to Disclose
 
Yuting Zhao
No Relationships to Disclose